Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves - Wikidata - wikimedia - TriplyDB

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

http://www.wikidata.org/entity/Q24601144

about

Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.Pulmonary Vein Sleeves as a Pharmacologic Model for the Study of Atrial Fibrillation.QT response after a test dose and during maintenance therapy with AZD1305 in patients with atrial fibrillation: a double-blind, randomized, placebo-controlled trial.

P2860

Q35785780-C41FF459-BAD6-4F4B-8ABD-46569E75D840 Q35897540-0332E64F-0B2F-455B-B139-8968C81CA06F Q38226807-626AFEFD-A50B-4421-B5FC-461BEE9ABDB3 Q38490444-5B2D7E35-F116-4867-BEF7-3F1A8B803416

P2860

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

http://www.wikidata.org/entity/Q24601144

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@ast

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@en

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@nl

type

label

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@ast

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@en

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@nl

prefLabel

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@ast

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@en

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@nl

P1433

Q24601144-C84EAE87-2D38-4878-B020-E9B332B702BA

P1476

Q24601144-F7179B52-8944-4545-8BBA-F57429DDBF67

P2093

Q24601144-5087003A-8EE6-4C83-8DE9-A9746D754906

Q24601144-759CD9E1-B652-4A35-A770-CE0487CD5798

P2860

Q24601144-065C987F-0EB3-4A74-B549-333E66DDF0B4

Q24601144-178B6343-962D-4D07-811D-19833DE7BCE7

Q24601144-178D7A6D-E28F-4EA6-8554-9B864CBC3EA5

Q24601144-281D3FCC-E4F0-4794-B111-3C2E3B06E50A

Q24601144-2B3CCC64-69F9-4FAE-B1C5-E590CEF35FA3

Q24601144-2B50F660-C011-48E0-AEB3-D7944A19BE25

Q24601144-302672C1-BF92-49C1-A0A1-EB50959DA31C

Q24601144-3126D5BD-4764-4234-AA3D-5DF928E19522

Q24601144-4E46547B-19DF-4AAD-9459-CC6416B5B64E

Q24601144-681AD3D8-04FB-4D70-8AD1-5C8DDA637823

P304

Q24601144-E2139F24-0AA2-44F4-92A2-EE89775B50A4

P31

Q24601144-184E8700-4A30-4AF7-B57D-4D331F618D73

P356

Q24601144-39115480-E479-4348-9E88-E6040DE25ABF

P407

Q24601144-CB2FE979-F9D2-4755-89FF-094DB503E790

P433

Q24601144-10B036EC-7A2E-4C71-A585-205D81844EB9

P478

Q24601144-1CFC5B93-AD72-4CFD-8189-97608FA64FC4

P50

Q24601144-85B9719B-BFF3-4C56-8F1C-168AF1C8BB8F

P577

Q24601144-B7D255C0-2390-4FEA-A0C2-ABC206BD598B

P5875

Q24601144-12AB8CB6-049F-4EB4-9274-1846D87B5BB8

P698

Q24601144-F5221764-3A86-4CBB-926F-F0558D52ED9B

P921

Q24601144-14E41AB8-E895-445F-8895-87C4C9787551

P932

Q24601144-590CF75E-1C54-4FFC-8A18-8FCF769577D1

P356

JPET.110.166702

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Electrophysiologic and antiarrhythmic effects of AZD1305 in canine pulmonary vein sleeves

@en

P2093

Leif Carlsson

http://www.w3.org/2001/XMLSchema#string

Serge Sicouri

http://www.w3.org/2001/XMLSchema#string

P2860

AZD1305 exerts atrial predominant electrophysiological actions and is effective in suppressing atrial fibrillation and preventing its reinduction in the dog

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.

Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria

Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.

Assessment of the ion channel-blocking profile of the novel combined ion channel blocker AZD1305 and its proarrhythmic potential versus dofetilide in the methoxamine-sensitized rabbit in vivo.

Electrophysiology of pulmonary veins.

Late-phase 3 EAD. A unique mechanism contributing to initiation of atrial fibrillation

Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.

Potent antiarrhythmic effects of chronic amiodarone in canine pulmonary vein sleeve preparations

P304

255-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.110.166702

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

334

http://www.w3.org/2001/XMLSchema#string

P50

Charles Antzelevitch

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42833578

http://www.w3.org/2001/XMLSchema#string

P698

20360353

http://www.w3.org/2001/XMLSchema#string

P921

electrophysiology

P932

2912040

http://www.w3.org/2001/XMLSchema#string